表紙
市場調查報告書

疫苗佐劑的全球市場

Vaccine Adjuvants

出版商 Global Industry Analysts, Inc. 商品編碼 893764
出版日期 內容資訊 英文 277 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
疫苗佐劑的全球市場 Vaccine Adjuvants
出版日期: 2019年10月01日內容資訊: 英文 277 Pages
簡介

本報告提供全球疫苗佐劑市場相關分析,整體市場規模的成果值、預測值,及主要推動及阻礙市場要素,各用途、各類型、疾病的各類型、各給藥途徑、各對象及各企業的市場佔有率趨勢 (過去9年、今後8年份),今後的市場成長的方向性,各地區、主要國家的市場詳細趨勢等調查,再加上主要企業簡介等資訊。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值、預測值)
    • 各種類的市場佔有率結構 (最新值、預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模、佔有率趨勢預測:各地區/各國
    • 研究用
      • 市場規模 (過去9年、今後8年份)
      • 市場佔有率:各企業 (總計17年份)
    • 商用
    • 粒子場佐劑
    • 佐劑乳膠
    • 病原體成分
    • 混合佐劑
    • 其他的種類
    • 感染疾病
    • 癌症
    • 其他的疾病
    • 皮下途徑
    • 肌肉內途徑
    • 鼻腔內途徑
    • 口服
    • 其他
    • 人體疫苗
    • 動物用疫苗

第3章 市場分析

  • 各地區的市場分析
    • 美國
      • 市場基本資料
      • 疫苗佐劑的市場規模 (成果值、預測值)
      • 各企業市場佔有率
      • 各用途、各類型、各疾病類型、各給藥途徑、各對象的市場規模 (成果值、預測值)
    • 加拿大
    • 日本
    • 中國
    • 歐洲
      • 法國
      • 德國
      • 義大利
      • 英國
      • 其他
    • 亞太地區
    • 其他的國家 (RoW)

第4章 企業

  • AGENUS, INC.
  • AVANTI POLAR LIPIDS, INC.
  • BRENNTAG BIOSECTOR A/S (BRENNTAG AG的子公司)
  • CSL
  • INVIVOGEN
  • MVP LABORATORIES
  • NOVAVAX
  • OZ BIOSCIENCES SAS
  • SPI PHARMA
  • SEPPIC SA

第5章 相關分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP15427

Vaccine Adjuvants market worldwide is projected to grow by US$492.1 Million, driven by a compounded growth of 10.2%. Particulate Adjuvants, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$337.2 Million by the year 2025, Particulate Adjuvants will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$22 Million to the region's size and clout in the next 5 to 6 years. Over US$22.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Particulate Adjuvants will reach a market size of US$30.1 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.7% over the next couple of years and add approximately US$83.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Agenus, Inc.; Avanti Polar Lipids, Inc.; Brenntag Biosector A/S; CSL Ltd.; Invivogen; Mvp Laboratories Inc.; Novavax, Inc.; OZ Biosciences SAS; Seppic SA; SPI Pharma

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Vaccine Adjuvants Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Vaccine Adjuvants Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Vaccine Adjuvants Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Vaccine Adjuvants Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
  • TABLE 5: Research (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017
  • TABLE 6: Research (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
  • TABLE 7: Commercial (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 8: Commercial (Application) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2009-2017
  • TABLE 9: Commercial (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 10: Particulate Adjuvants (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 11: Particulate Adjuvants (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 12: Particulate Adjuvants (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Adjuvant Emulsions (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 14: Adjuvant Emulsions (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 15: Adjuvant Emulsions (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 16: Pathogen Components (Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 17: Pathogen Components (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 18: Pathogen Components (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Combination Adjuvants (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 20: Combination Adjuvants (Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 21: Combination Adjuvants (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Other Types (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 23: Other Types (Type) Historic Market Analysis by Region/Country in US$ Thousand:
  • 2009 to 2017
  • TABLE 24: Other Types (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Infectious Diseases (Disease Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 26: Infectious Diseases (Disease Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 27: Infectious Diseases (Disease Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Cancer (Disease Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 29: Cancer (Disease Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 30: Cancer (Disease Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 31: Other Disease Types (Disease Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 32: Other Disease Types (Disease Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 33: Other Disease Types (Disease Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 34: Subcutaneous (Route of Administration) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 35: Subcutaneous (Route of Administration) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 36: Subcutaneous (Route of Administration) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 37: Intramuscular (Route of Administration) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 38: Intramuscular (Route of Administration) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017
  • TABLE 39: Intramuscular (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 40: Intranasal Route (Route of Administration) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 41: Intranasal Route (Route of Administration) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 42: Intranasal Route (Route of Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 43: Oral Route (Route of Administration) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 44: Oral Route (Route of Administration) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 45: Oral Route (Route of Administration) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 46: Other Route of Administrations (Route of Administration) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 47: Other Route of Administrations (Route of Administration) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 48: Other Route of Administrations (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 49: Human Vaccine Adjuvants (Application Category) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 50: Human Vaccine Adjuvants (Application Category) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 51: Human Vaccine Adjuvants (Application Category) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 52: Veterinary Vaccine Adjuvants (Application Category) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 53: Veterinary Vaccine Adjuvants (Application Category) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 54: Veterinary Vaccine Adjuvants (Application Category) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Vaccine Adjuvants Market Share (in %) by Company: 2019 & 2025
    • TABLE 55: United States Vaccine Adjuvants Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025
    • TABLE 56: Vaccine Adjuvants Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017
    • TABLE 57: Vaccine Adjuvants Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
    • TABLE 58: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
    • TABLE 59: Vaccine Adjuvants Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 60: United States Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 61: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 62: Vaccine Adjuvants Market in the United States by Disease Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 63: United States Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 64: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Route of Administration: 2018 to 2025
    • TABLE 65: Vaccine Adjuvants Market in the United States by Route of Administration: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 66: United States Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
    • TABLE 67: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Application Category: 2018 to 2025
    • TABLE 68: Vaccine Adjuvants Market in the United States by Application Category: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 69: United States Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 70: Canadian Vaccine Adjuvants Market Quantitative Demand Analysis in US$ Thousand
    • by Application: 2018 to 2025
    • TABLE 71: Vaccine Adjuvants Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017
    • TABLE 72: Canadian Vaccine Adjuvants Market Share Analysis by Application:
  • 2009 VS 2019 VS 2025
    • TABLE 73: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
    • TABLE 74: Canadian Vaccine Adjuvants Historic Market Review by Type in US$ Thousand:
  • 2009-2017
    • TABLE 75: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 76: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 77: Canadian Vaccine Adjuvants Historic Market Review by Disease Type in US$ Thousand: 2009-2017
    • TABLE 78: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
    • TABLE 79: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018 to 2025
    • TABLE 80: Canadian Vaccine Adjuvants Historic Market Review by Route of Administration in US$ Thousand: 2009-2017
    • TABLE 81: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
    • TABLE 82: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Application Category: 2018 to 2025
    • TABLE 83: Canadian Vaccine Adjuvants Historic Market Review by Application Category
    • in US$ Thousand: 2009-2017
    • TABLE 84: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Application Category for 2009, 2019, and 2025
  • JAPAN
    • TABLE 85: Japanese Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025
    • TABLE 86: Japanese Vaccine Adjuvants Market in US$ Thousand by Application: 2009-2017
    • TABLE 87: Vaccine Adjuvants Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
    • TABLE 88: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
    • TABLE 89: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
    • TABLE 90: Japanese Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 91: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections
    • in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 92: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017
    • TABLE 93: Japanese Vaccine Adjuvants Market Share Analysis by Disease Type:
  • 2009 VS 2019 VS 2025
    • TABLE 94: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025
    • TABLE 95: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017
    • TABLE 96: Japanese Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
    • TABLE 97: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Application Category for the Period 2018-2025
    • TABLE 98: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Application Category for the Period 2009-2017
    • TABLE 99: Japanese Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 100: Chinese Demand for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025
    • TABLE 101: Vaccine Adjuvants Market Review in China in US$ Thousand by Application: 2009-2017
    • TABLE 102: Chinese Vaccine Adjuvants Market Share Breakdown by Application:
  • 2009 VS 2019 VS 2025
    • TABLE 103: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
    • TABLE 104: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Type: 2009-2017
    • TABLE 105: Chinese Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 106: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 107: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Disease Type: 2009-2017
    • TABLE 108: Chinese Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 109: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025
    • TABLE 110: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Route of Administration: 2009-2017
    • TABLE 111: Chinese Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 112: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Application Category for the Period 2018-2025
    • TABLE 113: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Application Category: 2009-2017
    • TABLE 114: Chinese Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Vaccine Adjuvants Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 115: European Vaccine Adjuvants Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 116: Vaccine Adjuvants Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 117: European Vaccine Adjuvants Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 118: European Vaccine Adjuvants Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 119: Vaccine Adjuvants Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017
    • TABLE 120: European Vaccine Adjuvants Market Share Analysis by Application:
  • 2009 VS 2019 VS 2025
    • TABLE 121: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
    • TABLE 122: Vaccine Adjuvants Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017
    • TABLE 123: European Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 124: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025
    • TABLE 125: Vaccine Adjuvants Market in Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 126: European Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 127: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025
    • TABLE 128: Vaccine Adjuvants Market in Europe in US$ Thousand by Route of Administration:
    • A Historic Review for the Period 2009-2017
    • TABLE 129: European Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
    • TABLE 130: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand
    • by Application Category: 2018-2025
    • TABLE 131: Vaccine Adjuvants Market in Europe in US$ Thousand by Application Category:
    • A Historic Review for the Period 2009-2017
    • TABLE 132: European Vaccine Adjuvants Market Share Breakdown by Application Category:
  • 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 133: Vaccine Adjuvants Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025
    • TABLE 134: French Vaccine Adjuvants Historic Market Review in US$ Thousand by Application: 2009-2017
    • TABLE 135: French Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
    • TABLE 136: Vaccine Adjuvants Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 137: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Type:
  • 2009-2017
    • TABLE 138: French Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 139: Vaccine Adjuvants Market in France by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 140: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Disease
    • Type: 2009-2017
    • TABLE 141: French Vaccine Adjuvants Market Share Analysis by Disease Type:
  • 2009 VS 2019 VS 2025
    • TABLE 142: Vaccine Adjuvants Market in France by Route of Administration: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 143: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Route of Administration: 2009-2017
    • TABLE 144: French Vaccine Adjuvants Market Share Analysis by Route of Administration:
  • 2009 VS 2019 VS 2025
    • TABLE 145: Vaccine Adjuvants Market in France by Application Category: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 146: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Application Category: 2009-2017
    • TABLE 147: French Vaccine Adjuvants Market Share Analysis by Application Category:
  • 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 148: Vaccine Adjuvants Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025
    • TABLE 149: German Vaccine Adjuvants Market in Retrospect in US$ Thousand by Application: 2009-2017
    • TABLE 150: Vaccine Adjuvants Market Share Distribution in Germany by Application:
  • 2009 VS 2019 VS 2025
    • TABLE 151: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
    • TABLE 152: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Type:
  • 2009-2017
    • TABLE 153: German Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 154: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 155: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017
    • TABLE 156: German Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 157: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025
    • TABLE 158: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017
    • TABLE 159: German Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
    • TABLE 160: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Application Category for the Period 2018-2025
    • TABLE 161: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Application Category: 2009-2017
    • TABLE 162: German Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 163: Italian Demand for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025
    • TABLE 164: Vaccine Adjuvants Market Review in Italy in US$ Thousand by Application: 2009-2017
    • TABLE 165: Italian Vaccine Adjuvants Market Share Breakdown by Application:
  • 2009 VS 2019 VS 2025
    • TABLE 166: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
    • TABLE 167: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Type:
  • 2009-2017
    • TABLE 168: Italian Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 169: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 170: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Disease Type: 2009-2017
    • TABLE 171: Italian Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 172: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025
    • TABLE 173: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Route of Administration: 2009-2017
    • TABLE 174: Italian Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 175: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Application Category for the Period 2018-2025
    • TABLE 176: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Application Category: 2009-2017
    • TABLE 177: Italian Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 178: United Kingdom Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025
    • TABLE 179: United Kingdom Vaccine Adjuvants Market in US$ Thousand by Application:
  • 2009-2017
    • TABLE 180: Vaccine Adjuvants Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
    • TABLE 181: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
    • TABLE 182: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
    • TABLE 183: United Kingdom Vaccine Adjuvants Market Share Analysis by Type:
  • 2009 VS 2019 VS 2025
    • TABLE 184: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 185: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017
    • TABLE 186: United Kingdom Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 187: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025
    • TABLE 188: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017
    • TABLE 189: United Kingdom Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
    • TABLE 190: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Application Category for the Period 2018-2025
    • TABLE 191: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Application Category for the Period 2009-2017
    • TABLE 192: United Kingdom Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 193: Rest of Europe Vaccine Adjuvants Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 194: Vaccine Adjuvants Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017
    • TABLE 195: Rest of Europe Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025
    • TABLE 196: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
    • TABLE 197: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017
    • TABLE 198: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 199: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025
    • TABLE 200: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 201: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 202: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025
    • TABLE 203: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Route of Administration: A Historic Review for the Period 2009-2017
    • TABLE 204: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
    • TABLE 205: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Application Category: 2018-2025
    • TABLE 206: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Application Category: A Historic Review for the Period 2009-2017
    • TABLE 207: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 208: Vaccine Adjuvants Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025
    • TABLE 209: Asia-Pacific Vaccine Adjuvants Historic Market Review in US$ Thousand by Application: 2009-2017
    • TABLE 210: Asia-Pacific Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
    • TABLE 211: Vaccine Adjuvants Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 212: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Type: 2009-2017
    • TABLE 213: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 214: Vaccine Adjuvants Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 215: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017
    • TABLE 216: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 217: Vaccine Adjuvants Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 218: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Route of Administration: 2009-2017
    • TABLE 219: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
    • TABLE 220: Vaccine Adjuvants Market in Asia-Pacific by Application Category: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 221: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Application Category: 2009-2017
    • TABLE 222: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 223: Rest of World Vaccine Adjuvants Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    • TABLE 224: Vaccine Adjuvants Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017
    • TABLE 225: Rest of World Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025
    • TABLE 226: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
    • TABLE 227: Rest of World Vaccine Adjuvants Historic Market Review by Type in US$ Thousand: 2009-2017
    • TABLE 228: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 229: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 230: Rest of World Vaccine Adjuvants Historic Market Review by Disease Type in US$ Thousand: 2009-2017
    • TABLE 231: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Sales
    • by Disease Type for 2009, 2019, and 2025
    • TABLE 232: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand
    • by Route of Administration: 2018 to 2025
    • TABLE 233: Rest of World Vaccine Adjuvants Historic Market Review by Route of Administration
    • in US$ Thousand: 2009-2017
    • TABLE 234: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Sales
    • by Route of Administration for 2009, 2019, and 2025
    • TABLE 235: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand
    • by Application Category: 2018 to 2025
    • TABLE 236: Rest of World Vaccine Adjuvants Historic Market Review by Application Category
    • in US$ Thousand: 2009-2017
    • TABLE 237: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Sales by Application Category for 2009, 2019, and 2025

IV. COMPETITION

  • AGENUS, INC.
  • AVANTI POLAR LIPIDS, INC.
  • BRENNTAG BIOSECTOR A/S (A SUBSIDIARY OF BRENNTAG AG)
  • CSL
  • INVIVOGEN
  • MVP LABORATORIES
  • NOVAVAX
  • OZ BIOSCIENCES SAS
  • SPI PHARMA
  • SEPPIC SA

V. CURATED RESEARCH

Back to Top